•  
  •  
  •  
  •  

2025-07-11 20:46:04

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lemon Tree Hotels signs two new properties in Maharashtra
  • Canara Bank Donates ₹96.15 Lakhs for Life-Saving Pediatric Cardiac Equipment at Sri Sathya Sai Sanjeevani Hospital, Palwal, Haryana
  • RMC Switchgears sees over 165% Year-on-Year Growth in Q1 Sales for FY 2025-26
  • Nila Spaces Launches 'PRANA' - A First-of-Its-Kind Power Living Community at GIFT City
  • Ichnos Glenmark Innovation announces Global Commercialization Strategy for ISB 2001 Following Licensing Deal with AbbVie

Keywords Selected:  SanofiIndia

Research

  • Sanofi India - Curtailed expenses lift margins - ICICI Securities

Stock Report

  • Sanofi India Ltd Q1CY25 net profit at Rs. 119.5 crores
  • Sanofi India Ltd Q2CY24 consolidated profit at Rs. 103.2 crores
  • Sanofi India Ltd fixes record date for demerger
  • Sanofi India Ltd Q1 CY2024 net profit declines to Rs. 136.6 crores
  • Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in India
  • Sanofi India Ltd and Emcure Pharmaceuticals announce exclusive distribution partnership to broaden reach of Sanofi's Cardiovascular brands
  • Sanofi India posts net profit of Rs. 137.7 crores in Q4 CY2023
  • Sanofi India Limited declares interim dividend of Rs. 50 and final dividend of Rs. 117
  • Sanofi India Ltd recommends final dividend of Rs. 194, 2nd special dividend of Rs. 183
  • Sanofi India Ltd Q4 CY2022 net profit at Rs. 130.9 crores
  • Sanofi India Ltd Q3CY22 net profit at Rs. 130.9 crores
  • Sanofi India Ltd declares one-time special interim dividend of Rs. 193
  • Sanofi India Ltd Q2 CY2022 PAT declines to Rs. 120.4 crores
  • Sanofi India Q1CY22 net profit surges to Rs. 238.4 crores
  • Sanofi India appoints new Managing Director
  • Sanofi India declares INR 490 dividend per share on the back of divestments and strong domestic growth
  • Sanofi India Ltd recommends final dividend of Rs. 181, special dividend of Rs. 309
  • Sanofi India posts CY2021 net profit of Rs. 944.4 crores
  • Sanofi India Ltd updates on divestment of Soframycin® and Sofradex® businesses
  • Sanofi India Ltd Q3CY21 PAT at Rs. 529.8 crore

Latest Post

  • Lemon Tree Hotels signs two new properties in Maharashtra
  • Canara Bank Donates ₹96.15 Lakhs for Life-Saving Pediatric Cardiac Equipment at Sri Sathya Sai Sanjeevani Hospital, Palwal, Haryana
  • RMC Switchgears sees over 165% Year-on-Year Growth in Q1 Sales for FY 2025-26
  • Nila Spaces Launches 'PRANA' - A First-of-Its-Kind Power Living Community at GIFT City
  • Ichnos Glenmark Innovation announces Global Commercialization Strategy for ISB 2001 Following Licensing Deal with AbbVie


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024